2017 MDUFA Reauthorization Meetings Get Early Start

Anticipating delays typically experienced during  presidential elections, Congress and the U.S. Food and Drug Administration  (FDA) are starting the 2017 Medical Device User Fee Amendments (MDUFA)  Reauthorization negotiations nearly 2 years ahead of schedule.

To View Full Article You Must

Advertisements

Advertisement